SCHEMBL363574

SCHEMBL363574

C1=CC2=C(CC1)c1ccccc1C=CS2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9373408 0.74
SCHEMBL28818136 0.67
SCHEMBL27784702 0.65 ALDH1A1 (0.38)
SCHEMBL17261614 0.63 MEN1 (0.42)
SCHEMBL14080053 0.62 KDM4E (0.35)
SCHEMBL563542 0.62 KDM4E (0.35)
SCHEMBL9544601 0.62 TRPA1 (0.33)
SCHEMBL24611757 0.62 EPHA4 (0.35)
SCHEMBL4809415 0.61
SCHEMBL19504384 0.61 ACHE (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130143869-A1 USE OF A CATIONIC AMPHIPHILIC DRUG FOR THE PREPARATION OF A FORMULATION FOR THE REDUCTION OF SUBCUTANEOUS ADIPOSE TISSUE MERZ PHARMA GMBH & CO. KGAA (DE) 2013-06-06 US disclosed
EP-2593093-A1 USE OF A CATIONIC AMPHIPHILIC DRUG FOR THE PREPARATION OF A FORMULATION FOR THE REDUCTION OF SUBCUTANEOUS ADIPOSE TISSUE Merz Pharma GmbH & Co. KGaA (DE) 2013-05-22 EP disclosed
WO-2012007560-A1 USE OF A CATIONIC AMPHIPHILIC DRUG FOR THE PREPARATION OF A FORMULATION FOR THE REDUCTION OF SUBCUTANEOUS ADIPOSE TISSUE MERZ PHARMA GMBH & CO. KGAA (DE) 2012-01-19 WO disclosed